Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TSXV/COV stock hub

TSXV/COV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/COVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

53.9M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/COV

In the news

Latest news · TSXV/COV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.3

P25 11P50 15.6P75 25.4

Trailing P/E56.7

P25 7.4P50 15.6P75 34.3

ROE3.4

P25 -121.5P50 -40.9P75 0.5

ROIC1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/COV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

CAD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	37
Enterprise value	CAD 38M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CA22282D3022
Last refreshed	2026-05-10
Market cap	CAD 53.9M
Price	CAD 1.95
Price currency	CAD
Rev Per Employee	852,396.46x
Sector	Healthcare
Sic	2836
Symbol	tsxv/COV
Website	https://covalon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.81%
EV Earnings	38.92x
EV/EBIT	75.9x
EV/EBITDA	34.92x
EV/FCF	5.65x
EV/Sales	1.21x
FCF yield	12.49%
Forward P/E	22.29x
P/B ratio	2.04x
P/E ratio	56.74x
P/S ratio	1.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.59%
EBITDA Margin	2.42%
FCF margin	21.34%
Gross margin	52.27%
Gross Profit	CAD 16.5M
Gross Profit Growth	-21.79%
Gross Profit Growth Q	-19.75%
Gross Profit Growth3 Y	22.83%
Gross Profit Growth5 Y	70.42%
Net Income	CAD 977,420
Net Income Growth	-79.32%
Net Income Growth Q	-89.6%
Net Income Growth Years	0%
Pretax Margin	3.1%
Profit Margin	3.1%
Profit Per Employee	CAD 26,417
Profitable Years	2
ROA	0.93
Roa5y	-3.39
ROCE	1.79
ROE	3.43
Roe5y	-6.46
ROIC	1.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.28%
Cagr15y	0.29%
Cagr1y	-16.44%
Cagr20y	-4.22%
Cagr3y	1.13%
Cagr5y	6.85%
EPS Growth	-80.75
EPS Growth Q	-88.72
EPS Growth Years	0
FCF Growth	111.79%
FCF Growth Q	32,622.04%
FCF Growth5 Y	96.89%
OCF Growth	126.03%
OCF Growth Q	4,518.89%
OCF Growth5 Y	80%
Revenue Growth	-9.04x
Revenue Growth Q	-15.65x
Revenue Growth Years	3x
Revenue Growth3 Y	17.59x
Revenue Growth5 Y	31.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.93
Assets	CAD 32.8M
Cash	CAD 17.9M
Current Assets	CAD 27.7M
Current Liabilities	CAD 4.9M
Debt	CAD 2.1M
Debt EBITDA	CAD 1.9
Debt Equity	CAD 0.08
Debt FCF	CAD 0.31
Equity	CAD 26.4M
Liabilities	CAD 6.4M
Long Term Assets	CAD 5.1M
Long Term Liabilities	CAD 1.5M
Net Cash	CAD 15.8M
Net Cash By Market Cap	CAD 29.36
Net Cash Growth	-5.38%
Net Debt EBITDA	CAD -20.73
Net Debt Equity	CAD -0.6
Net Debt FCF	CAD -2.35
Tangible Book Value	CAD 25.1M
Tangible Book Value Per Share	CAD 0.91
WACC	4.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.69
Inventory Turnover	1.96
Net Working Capital	CAD 5.5M
Quick ratio	4.12
Working Capital	CAD 22.9M
Working Capital Turnover	CAD 1.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.87%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CAD 0.15
Dividend Years	1
Dividend Yield	7.58%
Ex Div Date	2025-11-04
Last Dividend	CAD 0.15
Payout Ratio	423.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	142.94%
1Y total return	-16.43%
200-day SMA	2
3Y total return	3.43%
50-day SMA	1.86
50-day SMA vs 200-day SMA	50under200
5Y total return	39.29%
All Time High	38.5
All Time High Change	-94.94%
All Time High Date	2007-11-06
All Time Low	0.13
All Time Low Change	1,400%
All Time Low Date	2013-07-29
ATR	0.08
Beta	-0.01
Beta1y	0.56
Beta2y	0.08
Ch YTD	12.07
High	1.97
High52	3.1
High52 Date	2025-08-20
High52ch	-37.1%
Low	1.88
Low52	1.55
Low52 Date	2026-02-10
Low52ch	25.81%
Ma50ch	4.78%
Price vs 200-day SMA	-2.4%
RSI	56.7
RSI Monthly	46.01
RSI Weekly	51.64
Sharpe ratio	-0.13x
Sortino ratio	-0.06
Total Return	-0.3%
Tr YTD	12.07
Tr15y	4.46%
Tr1m	1.04%
Tr1w	0.52%
Tr3m	22.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 501,248
Operating Income Growth	-89.85
Operating Income Growth Q	-96.03
Operating margin	1.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,593,352%
Net Borrowing	-790,019
Shares Insiders	30.22%
Shares Institutions	3.62%
Shares Out	27,618,077
Shares Qo Q	0.16%
Shares Yo Y	7.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 6.5M
Average Volume	7,342.3x
Bv Per Share	0.96
CAPEX	CAD -1.2M
Ch10y	126.7
Ch15y	-2.5
Ch1m	1.04
Ch1w	0.52
Ch1y	-22
Ch20y	-60.61
Ch3m	22.64
Ch3y	-3.47
Ch5y	30
Ch6m	-2.99
Change	1.04%
Change From Open	3.17
Close	1.93
Days Gap	-2.07
Depreciation Amortization	261,425
Dollar Volume	32,886.8
Earnings Date	2026-02-25
EBIT	CAD 501,248
EBITDA	CAD 762,673
EPS	CAD 0.03
F Score	4
FCF	CAD 6.7M
FCF EV Yield	17.69x
FCF Per Share	CAD 0.24
Financing CF	-4,735,522
Fiscal Year End	September
Founded	2,004
Graham Number	0.85964
Graham Upside	-55.92
Investing CF	-1,373,454
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Date	2013-07-16
Last Split Type	Reverse
Ma150	1.87
Ma150ch	4.33%
Ma20	1.92
Ma20ch	1.56%
Net CF	380,491
Open	1.89
P FCF Ratio	8
P OCF Ratio	6.8
Payment Date	2025-11-18
Position In Range	77.78
Ppne	3,730,589
Price Date	2026-05-08
Price EBITDA	CAD 70.61
Ptbv Ratio	2.15
Relative Volume	2.56x
Revenue	31,538,669x
SBC By Revenue	0.8x
Share Based Comp	251,082
Tr20y	-57.79%
Tr6m	-2.99%
Volume	16,865
Z Score	6.45

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TSXV/COV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.6%

$0.15 annual per share

Payout ratio

+423.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-0.3%

Next ex-dividend date: 2025-11-04

Performance

TSXV/COV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/COV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.6%

Share of float held by funds and institutions

Insider ownership

+30.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.9%

Negative means the company is buying back shares.

Technical

TSXV/COV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.7

Neutral momentum band

Price vs 200-day MA

-2.4%

50/200-day relationship not available

Beta (5Y)

-0.01

Less volatile than the market

Sharpe ratio

-0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/COV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/COV stock rating?

tsxv/COV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/COV analysis?

The full report lives at /stocks/tsxv/COV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/COV?

The latest report frames tsxv/COV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/COV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.